Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 09:02:15 GMT 2025
by
admin
on
Wed Apr 02 09:02:15 GMT 2025
|
| Protein Type | SINGLE-DOMAIN ANTIBODY |
| Protein Sub Type | BIVALENT VHH |
| Sequence Origin | CAMEL |
| Sequence Type | COMPLETE |
| Record UNII |
2R27AB6766
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1327
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
||
|
FDA ORPHAN DRUG |
277909
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
||
|
WHO-ATC |
B01AX07
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9511
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
DB06081
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
100000166854
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
915810-67-2
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
Caplacizumab
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
2110604
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
ALTERNATIVE | |||
|
2R27AB6766
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
AB-28
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
SUB181150
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
Caplacizumab
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
2110605
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
CHEMBL2109624
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
m12117
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
5308
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
2R27AB6766
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY | |||
|
C128625
Created by
admin on Wed Apr 02 09:02:15 GMT 2025 , Edited by admin on Wed Apr 02 09:02:15 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_153 | 1_227 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INNOVATOR->PARENT |
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|